StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Bully88on Jul 20, 2020 12:49pm

175 Views

Post# 31291098

RE:RE:RE:RE:RE:A 2nd shift in the lab!!

this stock will float here until they release numbers

szls knows this and are waiting to be able to announce massive news

why waste an opportunity like this to come out and say we did 1000 tests in q 2 and made 75 k when they can wait and say we are now at max operating cpacity and proessing thousands of tests a day

they are printing money as we speak.

patience will be rewarded.

load up while you can